APA (7th ed.) Citation

Stegemann, M., Macherndl-Spandl, S., Mairhofer, M., Kaltenbrunner, S., Buxhofer-Ausch, V., Clausen, J., . . . Schmitt, C. A. (2026). Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report. Leukemia & Lymphoma, 67(5), 1147. https://doi.org/10.1080/10428194.2025.2591779

Chicago Style (17th ed.) Citation

Stegemann, Maike, Sigrid Macherndl-Spandl, Mario Mairhofer, Sabine Kaltenbrunner, Veronika Buxhofer-Ausch, Johannes Clausen, Andreas Petzer, and Clemens A. Schmitt. "Simultaneous Auto-transplant and CD19 CAR T-cell 2nd Line Therapy Followed by CD20 × CD3 Bispecific Antibody for Refractory Burkitt Lymphoma, a Case Report." Leukemia & Lymphoma 67, no. 5 (2026): 1147. https://doi.org/10.1080/10428194.2025.2591779.

MLA (9th ed.) Citation

Stegemann, Maike, et al. "Simultaneous Auto-transplant and CD19 CAR T-cell 2nd Line Therapy Followed by CD20 × CD3 Bispecific Antibody for Refractory Burkitt Lymphoma, a Case Report." Leukemia & Lymphoma, vol. 67, no. 5, 2026, p. 1147, https://doi.org/10.1080/10428194.2025.2591779.